title: Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et al.
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: K A
authors: KA
authors: van Schie
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: M H
authors: MH
authors: Hart
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: E R
authors: ER
authors: de Groot
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: S
authors: S
authors: Kruithof
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: L A
authors: LA
authors: Aarden
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
authors: G J
authors: GJ
authors: Wolbink
authors: Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors: T
authors: T
authors: Rispens
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology*; D057134:Antibodies, Neutralizing / Q000276:immunology*; D018501:Antirheumatic Agents / Q000276:immunology*; D001666:Binding Sites, Antibody / Q000276:immunology*; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D057134:Antibodies, Neutralizing; D018501:Antirheumatic Agents
keywords: Anti-TNF; Inflammation; Treatment